Corticosterone selectively targets endo-cortical surfaces by an osteoblast-dependent mechanism
- 31 October 2011
- journal article
- Published by Elsevier BV in Bone
- Vol. 49 (4), 733-742
- https://doi.org/10.1016/j.bone.2011.06.013
Abstract
No abstract availableKeywords
Funding Information
- National Health & Medical Research Council, Australia (402462, 632819)
- Akademie der Naturforscher Leopoldina (BMBF-LPD 9901/8-155)
This publication has 29 references indexed in Scilit:
- Glucocorticoids Suppress Bone Formation by Attenuating Osteoblast Differentiation via the Monomeric Glucocorticoid ReceptorCell Metabolism, 2010
- Divergent Effects of Glucocorticoids on Cortical and Trabecular Compartment BMD in Childhood Nephrotic SyndromeJournal of Bone and Mineral Research, 2009
- Inflammation, glucocorticoids and risk of cardiovascular diseaseNature Clinical Practice Rheumatology, 2008
- Dose-related patterns of glucocorticoid-induced side effectsAnnals Of The Rheumatic Diseases, 2008
- Mechanisms of glucocorticoid-induced myopathyJournal of Endocrinology, 2008
- Effect of Dexamethasone on Glucose Tolerance and Fat Metabolism in a Diet-Induced Obesity Mouse ModelEndocrinology, 2007
- Long-Term, High-Dose Glucocorticoids and Bone Mineral Content in Childhood Glucocorticoid-Sensitive Nephrotic SyndromeNew England Journal of Medicine, 2004
- Altered skin development and impaired proliferative and inflammatory responses in transgenic mice overexpressing the glucocorticoid receptorThe FASEB Journal, 2001
- Alendronate for the Prevention and Treatment of Glucocorticoid-Induced OsteoporosisNew England Journal of Medicine, 1998
- Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.JCI Insight, 1998